Pulmonary Fibrosis
|
0.330 |
AlteredExpression
|
disease |
BEFREE |
Importantly, dysregulation is observed as a chronic inflammation, which can progress into pneumonitis and promote pulmonary fibrosis; inflammatory monocytes, which are bone marrow derived and express CCR2, have been shown to migrate into the lung after radiation exposure.
|
29332538 |
2018 |
Pulmonary Fibrosis
|
0.330 |
Biomarker
|
disease |
BEFREE |
Animal models have suggested that CCR2-dependent signalling contributes to the pathogenesis of pulmonary fibrosis, but global blockade of CCL2 failed to improve the clinical course of patients with lung fibrosis.
|
28780502 |
2017 |
Pulmonary Fibrosis
|
0.330 |
Biomarker
|
disease |
BEFREE |
Consistent with the development of diffuse lesions, genes that were differentially expressed in CD45(-) tissue cells from the lung of wild-type and Ccr2(-/-) mice were highly enriched in human diffuse, progressive PF.
|
26456580 |
2015 |
Pulmonary Fibrosis
|
0.330 |
Biomarker
|
disease |
CTD_human |
To evaluate the role of CCR2 in lung fibrosis, CCR2 knockout (ko) mice were used in a model of bleomycin-induced lung fibrosis.
|
14609568 |
2003 |
Status Epilepticus
|
0.320 |
Biomarker
|
disease |
BEFREE |
Daily oral treatment with CCR2 antagonist or vehicle was initiated 5 h following SE and lasted 5 or 10 days.
|
31785482 |
2020 |
Liver diseases
|
0.320 |
Biomarker
|
group |
BEFREE |
Inhibition of CCR2 in mice inhibits hepatic inflammation caused by a murine homolog of these myeloid cells and improves experimental liver disease.
|
29420066 |
2018 |
Pneumonitis
|
0.320 |
AlteredExpression
|
disease |
BEFREE |
Importantly, dysregulation is observed as a chronic inflammation, which can progress into pneumonitis and promote pulmonary fibrosis; inflammatory monocytes, which are bone marrow derived and express CCR2, have been shown to migrate into the lung after radiation exposure.
|
29332538 |
2018 |
Status Epilepticus
|
0.320 |
Biomarker
|
disease |
BEFREE |
We further showed that CCR2 activation induced STAT3 (signal transducer and activator of transcription 3) phosphorylation and IL-1β production, which are critical for promoting neuronal cell death after status epilepticus.
|
28716963 |
2017 |
Pneumonitis
|
0.320 |
Biomarker
|
disease |
BEFREE |
Lung inflammation in tissue from subjects with nondiseased lungs donated for lung transplantation (n = 11) and those with chronic obstructive pulmonary disease (COPD) who were undergoing lung transplantation (n = 16) was evaluated for CCR2 with immunostaining and autoradiography (n = 6, COPD) with <sup>64</sup>Cu-DOTA-ECL1i.
|
28045644 |
2017 |
Pneumonitis
|
0.320 |
Biomarker
|
disease |
CTD_human |
Expansion of CD4(+) CD25(+) and CD25(-) T-Bet, GATA-3, Foxp3 and RORγt cells in allergic inflammation, local lung distribution and chemokine gene expression.
|
21625544 |
2011 |
Status Epilepticus
|
0.320 |
Biomarker
|
disease |
CTD_human |
CCR3, CCR2A and macrophage inflammatory protein (MIP)-1a, monocyte chemotactic protein-1 (MCP-1) in the mouse hippocampus during and after pilocarpine-induced status epilepticus (PISE) .
|
19490431 |
2009 |
Status Epilepticus
|
0.320 |
Biomarker
|
disease |
CTD_human |
Increased CCR2 was observed in the hippocampus after SE.
|
20034406 |
2009 |
Liver diseases
|
0.320 |
Biomarker
|
group |
CTD_human |
Profiles of liver cytokine RNA levels as well as serum cytokine levels revealed reduced expression of the Th1 cytokine IFN-gamma in CCR2-/- mice.
|
12845637 |
2003 |
Liver diseases
|
0.320 |
AlteredExpression
|
group |
BEFREE |
Six chemokine system polymorphisms (CCR5Delta32, CCR5 promoter 59029-G/A, CCR2 -64I, RANTES [regulated upon activation, normal T cells expressed and secreted] -403 -G/A, and -28 -C/G and stromal derived factor 1 -3'A) were studied in 417 patients with liver diseases (339 with hepatitis C) and 2380 blood donors.
|
12557141 |
2003 |
Pneumonia
|
0.310 |
Biomarker
|
disease |
BEFREE |
Lung inflammation in tissue from subjects with nondiseased lungs donated for lung transplantation (n = 11) and those with chronic obstructive pulmonary disease (COPD) who were undergoing lung transplantation (n = 16) was evaluated for CCR2 with immunostaining and autoradiography (n = 6, COPD) with <sup>64</sup>Cu-DOTA-ECL1i.
|
28045644 |
2017 |
Pneumonia
|
0.310 |
Biomarker
|
disease |
CTD_human |
Expansion of CD4(+) CD25(+) and CD25(-) T-Bet, GATA-3, Foxp3 and RORγt cells in allergic inflammation, local lung distribution and chemokine gene expression.
|
21625544 |
2011 |
Hepatitis, Toxic
|
0.300 |
Biomarker
|
disease |
CTD_human |
Phenotypic and genotypic assessment of concomitant drug-induced toxic effects in liver, kidney and blood.
|
20623750 |
2011 |
Hypersensitivity
|
0.300 |
Biomarker
|
group |
CTD_human |
Expansion of CD4(+) CD25(+) and CD25(-) T-Bet, GATA-3, Foxp3 and RORγt cells in allergic inflammation, local lung distribution and chemokine gene expression.
|
21625544 |
2011 |
Lobar Pneumonia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Expansion of CD4(+) CD25(+) and CD25(-) T-Bet, GATA-3, Foxp3 and RORγt cells in allergic inflammation, local lung distribution and chemokine gene expression.
|
21625544 |
2011 |
Drug-Induced Liver Disease
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Phenotypic and genotypic assessment of concomitant drug-induced toxic effects in liver, kidney and blood.
|
20623750 |
2011 |
Experimental Lung Inflammation
|
0.300 |
Biomarker
|
disease |
CTD_human |
Expansion of CD4(+) CD25(+) and CD25(-) T-Bet, GATA-3, Foxp3 and RORγt cells in allergic inflammation, local lung distribution and chemokine gene expression.
|
21625544 |
2011 |
Hepatitis, Drug-Induced
|
0.300 |
Biomarker
|
disease |
CTD_human |
Phenotypic and genotypic assessment of concomitant drug-induced toxic effects in liver, kidney and blood.
|
20623750 |
2011 |
Allergic Reaction
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Expansion of CD4(+) CD25(+) and CD25(-) T-Bet, GATA-3, Foxp3 and RORγt cells in allergic inflammation, local lung distribution and chemokine gene expression.
|
21625544 |
2011 |
Drug-Induced Acute Liver Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
Phenotypic and genotypic assessment of concomitant drug-induced toxic effects in liver, kidney and blood.
|
20623750 |
2011 |
Chemical and Drug Induced Liver Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
Phenotypic and genotypic assessment of concomitant drug-induced toxic effects in liver, kidney and blood.
|
20623750 |
2011 |